NO952205L - Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter - Google Patents

Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter

Info

Publication number
NO952205L
NO952205L NO952205A NO952205A NO952205L NO 952205 L NO952205 L NO 952205L NO 952205 A NO952205 A NO 952205A NO 952205 A NO952205 A NO 952205A NO 952205 L NO952205 L NO 952205L
Authority
NO
Norway
Prior art keywords
preparation
medicaments
heterocyclic carbamates
carbamates
heterocyclic
Prior art date
Application number
NO952205A
Other languages
English (en)
Other versions
NO952205D0 (no
Inventor
Thomas Pill
Peter Zeiller
Wolfram Raake
Reiner Klauser
Original Assignee
Luitpold Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Pharma Gmbh filed Critical Luitpold Pharma Gmbh
Publication of NO952205L publication Critical patent/NO952205L/no
Publication of NO952205D0 publication Critical patent/NO952205D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Denne oppfinnelse vedrører heterocykliske karbamater med formelen (I) (R2) (I) fremgangsmåter for deres fremstilling og medikamenter inne- holdende disse.
NO952205A 1993-10-04 1995-06-02 Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter NO952205D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4333761A DE4333761A1 (de) 1993-10-04 1993-10-04 Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
PCT/EP1994/003280 WO1995009842A1 (en) 1993-10-04 1994-10-04 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics

Publications (2)

Publication Number Publication Date
NO952205L true NO952205L (no) 1995-06-02
NO952205D0 NO952205D0 (no) 1995-06-02

Family

ID=6499349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952205A NO952205D0 (no) 1993-10-04 1995-06-02 Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter

Country Status (9)

Country Link
US (1) US5679677A (no)
EP (1) EP0649839A1 (no)
JP (1) JPH08504216A (no)
AU (1) AU684314B2 (no)
CA (1) CA2148361A1 (no)
DE (2) DE4333761A1 (no)
FI (1) FI952324A0 (no)
NO (1) NO952205D0 (no)
WO (1) WO1995009842A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407922B2 (en) * 2005-10-13 2008-08-05 S.C. Johnson & Son, Inc. Deodorizing compositions
US7261742B2 (en) * 2005-10-13 2007-08-28 S.C. Johnson & Son, Inc. Method of deodorizing a textile
AU2007282678B2 (en) * 2006-08-08 2012-09-27 Aska Pharmaceutical Co., Ltd. Quinazoline derivative
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
EA026578B1 (ru) 2007-01-22 2017-04-28 ДЖиТиЭкс, ИНК. Вещества, связывающие ядерные рецепторы
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
JP2010520875A (ja) 2007-03-09 2010-06-17 レノビス, インコーポレイテッド P2x7調節因子としてのビシクロヘテロアリール化合物およびその使用
ES2691671T3 (es) * 2010-06-24 2018-11-28 Alkermes Pharma Ireland Limited Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
CA2816022C (en) 2010-10-29 2019-09-10 Emory University Quinazoline derivatives, compositions, and uses related thereto
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
PT3052485T (pt) 2013-10-04 2021-10-22 Infinity Pharmaceuticals Inc Compostos heterocíclicos e suas utilizações
MX382033B (es) 2014-03-19 2025-03-13 Infinity Pharmaceuticals Inc Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2017048702A1 (en) 2015-09-14 2017-03-23 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE36226B1 (en) * 1935-11-11 1976-09-15 Shimamoto Takio Phthalazone derivatives
FR1460552A (fr) * 1965-04-22 1966-03-04 Agripat Sa Additifs à des nourritures pour animaux
NL6702189A (no) * 1967-02-14 1968-08-15
DE1807685A1 (de) * 1968-11-08 1970-08-06 Chinoin Gyogyszer Es Vegyeszet Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben
CH540266A (de) * 1968-12-04 1973-08-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Chinazolon-Derivaten
JPS5418270B2 (no) * 1971-12-06 1979-07-06
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
JPS5976069A (ja) * 1982-10-25 1984-04-28 Showa Denko Kk フタラゾン誘導体
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds

Also Published As

Publication number Publication date
FI952324A7 (fi) 1995-05-12
DE4333761A1 (de) 1995-04-06
NO952205D0 (no) 1995-06-02
JPH08504216A (ja) 1996-05-07
DE4345266A1 (de) 1995-06-29
CA2148361A1 (en) 1995-04-13
AU7784594A (en) 1995-05-01
FI952324L (fi) 1995-05-12
DE4345266C2 (de) 1996-12-19
AU684314B2 (en) 1997-12-11
US5679677A (en) 1997-10-21
EP0649839A1 (en) 1995-04-26
FI952324A0 (fi) 1995-05-12
WO1995009842A1 (en) 1995-04-13

Similar Documents

Publication Publication Date Title
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
NO305074B1 (no) Aminosyrederivater, medikamenter inneholdende disse forbindelser og anvendelser derav
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
DK104292D0 (da) Heterocycliske forbindelser og fremgangsmaade til deres fremstilling
NO932620L (no) Amindiol-proteaseinhibitorer
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
ZW189A1 (en) Chemical compounds
UA35574C2 (uk) Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі
DK0417698T3 (da) Aminosyrederivater med reninhæmmende egenskaber, fremgangsmåde til deres fremstilling, midler med indhold deraf og deres anvendelse
NO840048L (no) Disubstituerte prolinderivater, fremgangsmaate til deres fremstilling og deres anvendelse
DK270789A (da) Hirudin-derivater, deres fremstilling og anvendelse
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
DK0658585T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og midler indeholdende disse som antik
DK0998471T3 (da) Heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
ES2022342B3 (es) Hidrazinas n-(opcinalmente sustituidas)-n'-sustituidas-n, n'-disustituidas, insecticidas.
DK613687A (da) Kondenserede heterocycliske tetrahydroaminoquinolinoler og beslaegtede forbindelser, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
SI0736009T1 (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
ATE189894T1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
DK0527079T3 (da) N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO992316L (no) Benzensulfonamidderivater og legemidler inneholdende disse
ATE154027T1 (de) Glycosylamide von 2-aminoacylamino-2-desoxy- zuckern
ES2039260T3 (es) Derivado de 4-oxo-1,3-benzodioxano.
DK0635491T3 (da) (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.